ImageneBio (IMA) Other Working Capital Changes (2020 - 2025)
ImageneBio (IMA) posted Other Working Capital Changes of $1.2 million for Q3 2025, up 196.31% sequentially from -$1.2 million in Q2 2025, and down 49.91% YoY from $2.3 million in Q3 2024.
ImageneBio (IMA) Other Working Capital Changes (2020 - 2025) Analysis & Trends
ImageneBio has reported Other Working Capital Changes for 6 years, with the latest figure at $1.2 million in Q3 2025.
- Quarterly Other Working Capital Changes fell 49.91% year-over-year to $1.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$4.6 million (down 50577.78% YoY) and the FY2024 annual result came in at -$3.2 million, up 64.88% from the prior year.
- Other Working Capital Changes improved to $1.2 million in Q3 2025 per IMA's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.0 million in Q3 2025 and troughed at -$2.7 million in Q3 2022.
- A 5-year average of $82368.4 and a median of -$308000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2021 and 2024: Other Working Capital Changes slumped 31003.08% in 2021, then soared 293.76% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$20.2 million in 2021, then surged by 73.04% to -$5.4 million in 2022, then surged by 87.91% to -$659000.0 in 2023, then plunged by 486.8% to -$3.9 million in 2024, then surged by 129.74% to $1.2 million in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.2 million, -$1.2 million, and -$650000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | -1.21 Mn |
| Jun 30, 2025 | -1.21 Mn |
| Jun 30, 2025 | -1.21 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | -623,000.00 |
| Dec 31, 2024 | -623,000.00 |
| Dec 31, 2024 | -623,000.00 |
| Sep 30, 2024 | -306,000.00 |
| Sep 30, 2024 | -306,000.00 |
| Sep 30, 2024 | -306,000.00 |
| Jun 30, 2024 | 270,000.00 |
| Jun 30, 2024 | 270,000.00 |
| Jun 30, 2024 | 270,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Mar 31, 2024 | 269,000.00 |